Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cost of Managing AK Varies by Region

JAMA Dermatol; ePub 2017 Mar 1; Kirby, et al

Variation exists in actinic keratosis (AK) management cost within and between regions, according to a recent study. A retrospective cohort study was performed using data from the MarketScan medical claims database of continuously enrolled members with 2 or more claims for AK from January 1, 2008, to December 31, 2012. Annual costs of care were calculated for outpatient visits, AK destruction, and medications for AKs, and the total of these components. Researchers found:

  • Overall, data from 488,324 continuously enrolled members (mean [SD] age, 53.1[7.5] years; 243,662 women) with 2 or more claims for AK were included.
  • Overall, patients had 1,085,985 claims related to AK, and dermatologists accounted for 71.0% of claims.
  • The 2-year total cost was $111.5 million, with $52.4 million in 2011 and $59.1 million in 2012.

Citation:

Kirby JS, Gregory T, Liu G, Leslie DL, Miller JJ. Variation in the cost of managing actinic keratosis. [Published online ahead of print March 1, 2017]. JAMA Dermatol. doi:10.1001/jamadermatol.2016.4733.

This Week's Must Reads

Racial/Ethnic Differences in Childhood Eczema Care, J Am Acad Dermatol; 2017 Dec; Fischer, et al

Eczema Herpeticum Hospitalizations Increase Noted, J Invest Dermatol; ePub 2017 Sep 16; Hsu, Shinkai, et al

Atopic Dermatitis Linked with Hand Eczema, Br J Dermatol; ePub 2017 Nov 24; Ruff, et al

EAPs Aid Patients with Limited Health Literacy , J Cutan Med Surg; ePub 2017 Nov 3; McEvoy, et al

Phenotypical Differences of Adult, Childhood AD, J Allergy Clin Immunol; ePub 2017 Nov 10; Silverberg, et al

Must Reads in Actinic Keratosis

Cost of Managing AK Varies by Region, JAMA Dermatol; ePub 2017 Mar 1; Kirby, et al

Physician Wording Role in Seeking AK Treatment, JAMA Dermatol; ePub 2017 Jan 18; Berry, Butt, et al

Acantholysis in SCC Not Considered High Risk, J Am Acad Dermatol; ePub 2016 Nov 23; Ogawa, et al

Prevalence of Nonmelanoma Skin Cancers High in VHA, Dermatol Surg; ePub 2016 Jul 25; Yoon, Phibbs, et al

FDA Approves Ameluz for Actinic Keratosis, Biofrontera news release; 2016 May 11